Designed antiviral proteins inhibit SARS-CoV-2 in the lab



Computer-designed miniproteins have now been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19. The lead antiviral candidate rivals the best-known SARS-CoV-2 monoclonal antibodies in its protective actions. The synthetic antiviral candidates were designed to prevent infection by interfering with the mechanism that coronaviruses use to break into and enter cells.



Source link

We will be happy to hear your thoughts

Leave a reply

Virology Hub
Logo
Enable registration in settings - general
%d bloggers like this: